======= PLEKHA3 ======= == Gene Information == * **Official Symbol**: PLEKHA3 * **Official Name**: pleckstrin homology domain containing A3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=65977|65977]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HB20|Q9HB20]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLEKHA3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLEKHA3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607774|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in Golgi to cell surface membrane traffic. Induces membrane tubulation. Binds preferentially to phosphatidylinositol 4-phosphate (PtdIns4P). {ECO:0000269|PubMed:15107860}. |PH| |ER to Golgi ceramide transport| |ceramide 1-phosphate binding| |ceramide 1-phosphate transfer activity| |intermembrane lipid transfer| |ceramide 1-phosphate transport| |ceramide transport| |phosphatidylinositol-4-phosphate binding| |intracellular lipid transport| |phospholipid transport| |phosphatidylinositol biosynthetic process| |organophosphate ester transport| |lipid binding| |phosphatidylinositol metabolic process| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |phospholipid biosynthetic process| |lipid transport| |glycerophospholipid metabolic process| |lipid localization| |phospholipid metabolic process| |glycerolipid metabolic process| |organic anion transport| |organophosphate biosynthetic process| |lipid biosynthetic process| |anion transport| |Golgi membrane| |membrane organization| |organophosphate metabolic process| |cellular lipid metabolic process| |Golgi apparatus| |lipid metabolic process| |ion transport| |intracellular transport| |amide transport| |establishment of localization in cell| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-3.29| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-2.31| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-1.84| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-1.75| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.77| |[[:results:exp275|Citral 75μM R06 exp275]]|1.79| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.86| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|1.91| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|1.93| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15016 * **Expression level (log2 read counts)**: 4.58 {{:chemogenomics:nalm6 dist.png?nolink |}}